mRNA Vaccines: Current Applications and Future Directions
MedComm · 2025-11 · 6 (11)
DOI: 10.1002/mco2.70434 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift MedComm, online erschienen am 30.10.2025. Verfasst von Jianmei Li und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotherapy, Cancer Center West China Hospital, Sichuan University Chengdu Sichuan China. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 205 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Messenger RNA (mRNA) vaccines, as a novel class of biotherapeutics, leverage mRNA technology to instruct cells to produce specific antigens, thereby inducing an immune response. In recent years, significant progress has been made in applying these vaccines to infectious disease prevention and cancer treatment. Compared with traditional vaccines, mRNA vaccines offer high programmability, as well as greatly enhanced stability and immunogenicity, achieved through nucleotide modifications and advanced delivery systems such as lipid nanoparticles. However, many challenges remain in the design and delivery of mRNA vaccines, particularly for complex conditions like cancer. This review explores the latest advances and future prospects of mRNA vaccines in both infectious disease prevention and cancer therapy. It discusses the mechanisms of tumor immune escape and examines the potential of mRNA vaccines to overcome tumor immune resistance. The review also analyzes strategies for tumor vaccine design and the development of novel delivery systems, projecting the future role of mRNA vaccines in cancer therapy. By providing theoretical guidance and technical insights, this review aims to expand the development of mRNA vaccines across broader disease areas. It offers both a theoretical framework and a practical reference for researchers focused on infectious disease control and precision cancer immunotherapy. Ultimately, these insights will help advance the clinical application of next‐generation mRNA therapeutics.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biotherapy, Cancer Center West China Hospital, Sichuan University Chengdu Sichuan China.
- Department of Thoracic Surgery, West China Hospital, Sichuan University Chengdu Sichuan China.
- Department of High Altitude Medicine, Center for High Altitude Medicine West China Hospital, Sichuan University Chengdu Sichuan China.
- Department of Medical Oncology, Cancer Center, Lung Cancer Center West China Hospital, Sichuan University Chengdu Sichuan China.
- Department of Pulmonary and Critical Care Medicine West China Hospital, Sichuan University Chengdu Sichuan China.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Li, J., Liu, Y., Dai, J., Yang, L., Xiong, F., Xia, J., Jin, J., Wu, Y., & Peng, X. (2025). mRNA Vaccines: Current Applications and Future Directions. MedComm, 6(11). https://doi.org/10.1002/mco2.70434
Vancouver
Li J, Liu Y, Dai J, Yang L, Xiong F, Xia J, et al. mRNA Vaccines: Current Applications and Future Directions. MedComm. 2025;6(11). doi:10.1002/mco2.70434
BibTeX
@article{Li2025,
author = {Li, Jianmei and Liu, Yixin and Dai, Jie and Yang, Li and Xiong, Feng and Xia, Jing and Jin, Jing and Wu, Yangping and Peng, Xingchen},
title = {mRNA Vaccines: Current Applications and Future Directions},
journal = {MedComm},
year = {2025},
volume = {6},
number = {11},
doi = {10.1002/mco2.70434}
}
EUVIMED